Antiplasmodial activity of hydroxyethylamine analogs: Synthesis, biological activity and structure activity relationship of plasmepsin inhibitors. Issue 13 (30th July 2018)
- Record Type:
- Journal Article
- Title:
- Antiplasmodial activity of hydroxyethylamine analogs: Synthesis, biological activity and structure activity relationship of plasmepsin inhibitors. Issue 13 (30th July 2018)
- Main Title:
- Antiplasmodial activity of hydroxyethylamine analogs: Synthesis, biological activity and structure activity relationship of plasmepsin inhibitors
- Authors:
- Kumar Singh, Amit
Rajendran, Vinoth
Singh, Snigdha
Kumar, Prashant
Kumar, Yogesh
Singh, Archana
Miller, Whelton
Potemkin, Vladimir
Poonam,
Grishina, Maria
Gupta, Nikesh
Kempaiah, Prakasha
Durvasula, Ravi
Singh, Brajendra K.
Dunn, Ben M.
Rathi, Brijesh - Abstract:
- Graphical abstract: Abstract: Malaria, particularly in endemic countries remains a threat to the human health and is the leading the cause of mortality in the tropical and sub-tropical areas. Herein, we explored new C 2 symmetric hydroxyethylamine analogs as the potential inhibitors of Plasmodium falciparum ( P. falciparum ; 3D7) in in-vitro cultures. All the listed compounds were also evaluated against crucial drug targets, plasmepsin II (Plm II) and IV (Plm IV), enzymes found in the digestive vacuole of the P. falciparum . Analog10f showed inhibitory activities against both the enzymes Plm II and Plm IV (Ki, 1.93 ± 0.29 µM for Plm II; Ki, 1.99 ± 0.05 µM for Plm IV). Among all these analogs, compounds10g selectively inhibited the activity of Plm IV (Ki, 0.84 ± 0.08 µM). In the in vitro screening assay, the growth inhibition of P. falciparum by both the analogs (IC50, 2.27 ± 0.95 µM for10f ; IC50, 3.11 ± 0.65 µM for10g ) displayed marked killing effect. A significant growth inhibition of the P. falciparum was displayed by analog12c with IC50 value of 1.35 ± 0.85 µM, however, it did not show inhibitory activity against either Plms. The hemolytic assay suggested that the active compounds selectively inhibit the growth of the parasite. Further, potent analogs (10f and12c ) were evaluated for their cytotoxicity towards mammalian HepG2 and vero cells. The selectivity index (SI) values were noticed greater than 10 for both the analogs that suggested their poor toxicity. TheGraphical abstract: Abstract: Malaria, particularly in endemic countries remains a threat to the human health and is the leading the cause of mortality in the tropical and sub-tropical areas. Herein, we explored new C 2 symmetric hydroxyethylamine analogs as the potential inhibitors of Plasmodium falciparum ( P. falciparum ; 3D7) in in-vitro cultures. All the listed compounds were also evaluated against crucial drug targets, plasmepsin II (Plm II) and IV (Plm IV), enzymes found in the digestive vacuole of the P. falciparum . Analog10f showed inhibitory activities against both the enzymes Plm II and Plm IV (Ki, 1.93 ± 0.29 µM for Plm II; Ki, 1.99 ± 0.05 µM for Plm IV). Among all these analogs, compounds10g selectively inhibited the activity of Plm IV (Ki, 0.84 ± 0.08 µM). In the in vitro screening assay, the growth inhibition of P. falciparum by both the analogs (IC50, 2.27 ± 0.95 µM for10f ; IC50, 3.11 ± 0.65 µM for10g ) displayed marked killing effect. A significant growth inhibition of the P. falciparum was displayed by analog12c with IC50 value of 1.35 ± 0.85 µM, however, it did not show inhibitory activity against either Plms. The hemolytic assay suggested that the active compounds selectively inhibit the growth of the parasite. Further, potent analogs (10f and12c ) were evaluated for their cytotoxicity towards mammalian HepG2 and vero cells. The selectivity index (SI) values were noticed greater than 10 for both the analogs that suggested their poor toxicity. The present study indicates these analogs as putative lead structures and could serve as crucial for the development of new drug molecules. … (more)
- Is Part Of:
- Bioorganic & medicinal chemistry. Volume 26:Issue 13(2018)
- Journal:
- Bioorganic & medicinal chemistry
- Issue:
- Volume 26:Issue 13(2018)
- Issue Display:
- Volume 26, Issue 13 (2018)
- Year:
- 2018
- Volume:
- 26
- Issue:
- 13
- Issue Sort Value:
- 2018-0026-0013-0000
- Page Start:
- 3837
- Page End:
- 3844
- Publication Date:
- 2018-07-30
- Subjects:
- Phthalimide -- Hydroxyethylamine -- Antimalarial -- Drug resistance -- Plasmepsins
Bioorganic chemistry -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
Chemistry, Clinical -- Periodicals
Chemistry, Organic -- Periodicals
Chimie bio-organique -- Périodiques
Chimie pharmaceutique -- Périodiques
615.19 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09680896 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.bmc.2018.06.037 ↗
- Languages:
- English
- ISSNs:
- 0968-0896
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2089.325000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 6930.xml